• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W. L. GORE & ASSOCIATES, INC. GORE® VIATORR® TIPS ENDOPROSTHESIS WITH CONTROLLED EXPANSION; SHUNT, PORTOSYSTEMIC, ENDOPROSTHESIS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W. L. GORE & ASSOCIATES, INC. GORE® VIATORR® TIPS ENDOPROSTHESIS WITH CONTROLLED EXPANSION; SHUNT, PORTOSYSTEMIC, ENDOPROSTHESIS Back to Search Results
Catalog Number PT8108275
Device Problems Fracture (1260); Activation Failure (3270)
Patient Problem Liver Damage/Dysfunction (1954)
Event Date 05/12/2022
Event Type  Injury  
Event Description
It was reported to gore that the patient underwent endovascular treatment for a transjugular intrahepatic portosystemic shunt creation (tips) due to a budd-chiari-syndrom with a gore® viatorr® tips endoprosthesis with controlled expansion (viatorr-device).It was stated that a 10 fr cook flexor introducer sheath was used together with an 0.0035¿ amplatz guide wire.The viatorr-device was inserted and placed without any issues and there was no kinking due to a straight pathway.The uncovered baremetal segment was deployed without any problems.The deployment line of the covered endoprosthesis was pulled at first and the device began to deploy, but suddenly the line appeared to be blocked and broke.As the device was still connected to the delivery catheter, it was not possible to deploy the device.The device had to be removed from the patient with great efforts and the procedure was not finished according to plan.The patient tolerated the procedure.Reportedly, to rule out acute injuries, a ct scan of the thorax and abdomen was carried out immediately afterwards, which was able to exclude a relevant organ injury.The following night the hb decreased so that another ct scan and angiography were performed to rule out acute bleeding.Active bleeding could be excluded.The patient was listed as high urgency for liver transplantation.
 
Manufacturer Narrative
No patient specific details have been provided.Therefore, the patient initials reflect the w.L.Gore internal case number.(b)(4).A product history review, communication/interviews and an engineering investigation of the returned device will be performed.
 
Manufacturer Narrative
B1: adverse event instead of product problem (e.G., defects/malfunctions).B2: required intervention to prevent permanent impairment/damage (devices).H1: type of reportable event: serious injury instead of malfunction.
 
Manufacturer Narrative
Images and patient details will not be provided by the hospital.Therefore an imaging evaluation cannot be performed.H6 evaluation codes investigation findings 213 refers to the product history review: a review of the manufacturing records indicated the lots met pre-release specifications.Engineering investigation: - the endoprosthesis was returned partially deployed and without the delivery system.- intermittent sections of the endoprosthesis were unconstrained and constrained by the zipper.- the deployment line appeared to be cut as all four fibers that constitute the zipper/deployment line ended at the same place.- no anomalies were observed in the most distal zipper knot row.The physician¿s observation that the deployment line broke is confirmed, however how or when it broke could not be determined with the available information.With the information provided to gore, the cause of the reported event could not be established.In the instruction for use for the gore® viatorr® tips endoprosthesis with controlled expansion the following is stated: adverse events adverse events may include, but are not limited to: deployment failure, prosthesis/device failure.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE® VIATORR® TIPS ENDOPROSTHESIS WITH CONTROLLED EXPANSION
Type of Device
SHUNT, PORTOSYSTEMIC, ENDOPROSTHESIS
Manufacturer (Section D)
W. L. GORE & ASSOCIATES, INC.
1505 n. fourth street
flagstaff AZ 86004
Manufacturer (Section G)
MEDICAL PHOENIX 1 B/P
32360 n. north valley parkway
phoenix AZ 85085
Manufacturer Contact
gunter marte
1505 n. fourth street
flagstaff, AZ 86004
9285263030
MDR Report Key14630080
MDR Text Key293725157
Report Number3007284313-2022-01955
Device Sequence Number1
Product Code MIR
Combination Product (y/n)N
Reporter Country CodeGM
PMA/PMN Number
P040027
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,User Facility,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 07/20/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/08/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberPT8108275
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer05/23/2022
Is the Reporter a Health Professional? Yes
Date Manufacturer Received07/20/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured02/02/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
10 FR COOK FLEXOR SHEATH, 0.0035¿AMPLATZ
Patient Outcome(s) Other; Required Intervention;
Patient Age37 YR
Patient SexFemale
-
-